Proben-C Drug Interactions
Currently displaying 216 drugs known to have a moderate interaction with Proben-C (colchicine / probenecid).
Moderate interactions with Proben-C (colchicine / probenecid)
Note: Showing generic names only.
A
- abametapir topical
- acetohexamide
- adalimumab
- ado-trastuzumab emtansine
- alpelisib
- apalutamide
- aspirin
- auranofin
- aurothioglucose
- avacopan
- azathioprine
B
- belzutifan
- benznidazole
- betiatide
- bismuth subsalicylate
- blinatumomab
- bortezomib
- brentuximab
- brigatinib
C
- cabazitaxel
- capivasertib
- carboplatin
- carfilzomib
- cefaclor
- cefadroxil
- cefamandole
- cefazolin
- cefdinir
- cefepime
- cefixime
- cefmetazole
- cefonicid
- cefoperazone
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftaroline
- ceftibuten
- ceftizoxime
- cefuroxime
- cephalexin
- cephalothin
- cephapirin
- cephradine
- certolizumab
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- chlorpropamide
- choline salicylate
- cimetidine
- cisplatin
- clofibrate
D
- dapsone
- dasatinib
- deferasirox
- didanosine
- digoxin
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- doripenem
E
- echinacea
- edaravone
- efavirenz
- elagolix
- elotuzumab
- elranatamab
- eluxadoline
- enfortumab vedotin
- entecavir
- entrectinib
- enzalutamide
- epcoritamab
- erdafitinib
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etravirine
F
G
- ganciclovir
- gemfibrozil
- givinostat
- glasdegib
- glimepiride
- glipizide
- glofitamab
- glyburide
- gold sodium thiomalate
- golimumab
H
I
- ibrutinib
- indocyanine green
- indomethacin
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isoniazid
- ivosidenib
- ixabepilone
- ixazomib
L
- larotrectinib
- lefamulin
- leflunomide
- levodopa
- linezolid
- lonapegsomatropin
- loracarbef
- lorlatinib
- lumateperone
M
- magnesium salicylate
- mavacamten
- meropenem
- metronidazole
- miconazole
- mirvetuximab soravtansine
- monomethyl fumarate
- mosunetuzumab
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pemigatinib
- penicillamine
- pirtobrutinib
- polatuzumab vedotin
- pomalidomide
- pralatrexate
- pralsetinib
- pyrazinamide
R
S
- salsalate
- secnidazole
- selexipag
- selinexor
- selpercatinib
- sirolimus
- sodium phenylacetate
- sodium phosphate p32
- sodium salicylate
- sodium thiosalicylate
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- stavudine
T
- talquetamab
- tarlatamab
- tazobactam
- teclistamab
- telbivudine
- temsirolimus
- teniposide
- teriflunomide
- thalidomide
- ticagrelor
- tinidazole
- tisotumab vedotin
- tocilizumab
- tolazamide
- tolbutamide
- tolvaptan
- trabectedin
- trofinetide
U
V
Z
Proben-C alcohol/food interactions
There is 1 alcohol/food interaction with Proben-C (colchicine / probenecid).
Proben-C disease interactions
There are 12 disease interactions with Proben-C (colchicine / probenecid) which include:
- bone marrow suppression
- cardiac dysfunction
- DIC
- electrolyte disturbances
- liver disease
- renal dysfunction
- blood dyscrasias
- dehydration
- uric acid nephrolithiasis
- rhabdomyolysis
- PUD
- renal dysfunction
More about Proben-C (colchicine / probenecid)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antigout agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.